Elevance Health Inc. (ELV)

NYSE: ELV · Precio en tiempo real · USD

398.27

+8.03 (2.06%)

Al cierre: Aug 18, 2026, 8:00 PM

2.06% (1D)

No hay datos disponibles

Precio de compra	n/a
Capitalización de mercado	86.37B
Ingresos (TTM)	201.11B
Beneficio neto (TTM)	4.96B
Beta	0.69
EPS (TTM)	23.06
Ratio PER (TTM)	17.27
Adelante PE	13.44
P/B (TTM)	1.92
P/S (TTM)	0.43
Earnings Date	Oct 21, 2026

Precio de venta	n/a
Volumen	736,597
Volumen medio (20D)	1,517,646
Abierto	394.46
Anterior Cerrar	390.24
Rango del día	391.77 - 402.72
Rango de 52 semanas	274.84 - 436.24
analista	n/a
Precio objetivo	n/a
Dividendos	$6.88 (1.73%)
Fecha ex dividendo	10 sept 2026

Acerca de ELV

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care ser...

[Leer más]

Industria Healthcare Plans

Sector Healthcare

IPO Fecha Oct 30, 2001

Empleados 96,129

Bolsa de Valores NYSE

Símbolo bursátil ELV

Sitio web https://www.elevancehealth.com

Perfil completo de la empresa

Desempeño financiero

En 2025, los ingresos de Elevance Health fueron 199.13B, un aumento de 12.62% en comparación con 176.81B del año anterior. Las ganancias fueron 5.66B, una disminución de -5.32%.

Estados financieros

Sorpresa de resultados

Elevance Health ha publicado sus resultados trimestrales en Jul 15, 2026:

Ingresos de $50.47B falla las estimaciones por $0, con 1.40% Crecimiento interanual.

EPS de 7.45 supera las estimaciones en 1.24, con -15.72% Disminución interanual.

Próxima publicación de resultados

Está previsto que Elevance Health Inc. publique sus resultados el Oct 21, 2026, antes de que se abra el mercado.
Los analistas proyectan ingresos de ... Actualizar

Noticias

4 días hace · Zacks

Elevance Health (ELV) Up 6.8% Since Last Earnings Report: Can It Continue?

Elevance Health (ELV) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

4 días hace · MarketWatch

‘I didn’t know what else to do’: Patients take their health-insurance battles to Facebook and LinkedIn

Pushed to their limits, patients are turning to social media to plead for help getting their medical care covered.

5 días hace · Simply Wall St.

Is Elevance Health (ELV) Still A Bargain After A 38% Gain?

Elevance Health has delivered a 37.6% gain over the past year, yet current valuation checks still lean on the side of the stock looking inexpensive rather than stretched. For investors, that creates a...